HENWOOD GERALDINE (President and CEO) purchased 1.7% of their position (6K shares) of BAUDAX BIO, INC. on the open market
Open‑market purchase worth $5.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/10/2021ACC: 0001192482-21-000407
DirectorOfficer· President and CEO
Since Nov 2019
+6K
Net shares
Net buyer
$5.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6K
Price / share
$0.83
Trade value
$4.99K
% of position
1.7%
5/7/2021
350.31K→356.31K
Total
Net shares
+6K
Net value
$4.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/7/2021 | P · Purchase | +6K | $0.83 | $4.99K | 1.7% | 350.31K | 356.31K |
| Total | +6K | $4.99K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned20K
Total
20K indirect20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20K | Indirect |
| Total | 20K | 20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported